HealthQuill Articles by: HealthQuill
Nuravax Inc. and its partner, the Institute for Molecular Medicine, have received a $3 million grant from the National Institutes of Health to advance its Alzheimer’s vaccine to human trials.
Drugs Health Pharma

Nuravax’s Alzheimer’s vaccine gets $3m grant to enter human trials

HQ Team May 5, 2025: Nuravax Inc. and its partner, the Institute for Molecular Medicine, have received a $3 million grant from the

Read More
Scientists have developed a test by studying how an abnormally-shaped protein in the spinal fluid can detect 90% of Parkinson’s disease in patients, even before symptoms appear.
Drugs Health Research

New Parkinson’s test to detect disease even before symptoms appear

HQ Team May 5, 2025: Scientists have developed a test by studying how an abnormally-shaped protein in the spinal fluid can detect 90%

Read More
The Global Virus Network warned of an avian influenza currently circulating in the US, spreading to humans and urged enhanced surveillance, biosecurity measures and preparations for a potential human-to-human transmission.
Drugs Health Pharma

Global virologists see potential for an H5N1 pandemic, urge rapid steps

HQ Team May 5, 2025: The Global Virus Network warned of an avian influenza currently circulating in the US, spreading to humans and

Read More
UK scientists at biotech company Stablepharma have developed a tetanus-diphtheria vaccine that is completely stable at room temperature and does not need to be refrigerated or frozen.
Drugs Health Pharma

UK company starts trial on first ‘fridge-free’ tetanus-diphtheria vaccine

HQ Team May 1, 2025: UK scientists at biotech company Stablepharma Ltd. have developed a tetanus-diphtheria vaccine that is completely stable at room

Read More
Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new under-the-skin injection version of the cancer therapy, nivolumab (Opdivo), offering a quicker administration option for eligible patients than the currently available drip treatment. 
Drugs Medical Pharma

UK regulator clears subcutaneous injection of Bristol Myers for cancers

HQ Team May 1, 2025: Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new under-the-skin injection version of the cancer

Read More
Switzerland’s pharmaceutical company, Novartis AG,  will acquire Regulus Therapeutics for about $1.7 billion to get access to a drug to treat a genetic kidney disease called autosomal dominant polycystic kidney disease.
Drugs Health Pharma

Novartis buys Regulus for $1.7b to grab genetic kidney disease drug

HQ Team April 30, 2025: Switzerland’s pharmaceutical company, Novartis AG,  will acquire Regulus Therapeutics for about $1.7 billion to get access to a

Read More
Johnson & Johnson’s immune disorder drug has been approved by the US Food and Drug Administration for the treatment of generalised myasthenia gravis (gMG) — a rare disease that causes muscle weakness and affects daily activities like chewing, swallowing, speaking, and breathing.
Drugs Health Pharma

US regulator approves Johnson & Johnson’s immune disorder drug

HQ Team April 30, 2025: Johnson & Johnson’s immune disorder drug has been approved by the US Food and Drug Administration for the

Read More
Scientists in Britain have invented a material that allows teeth to be grown in a laboratory, a breakthrough which can replace painful dental implants and root canal treatments in the future.
Drugs Health Research

Scientists grow teeth in laboratory, future for implants, root canals uncertain

HQ Team April 30, 2025: Scientists in Britain have invented a material that allows teeth to be grown in a laboratory, a breakthrough

Read More
A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold this year until April 18, in the American region, according to two global health agencies.
Drugs Health Medical

In Europe measles up 10-fold last year, Americas region up by 11-fold in 2025

HQ Team April 29, 2025: A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold

Read More
British-Swedish pharmaceutical company AstraZeneca Plc. has discontinued its prostate cancer trial as it failed to meet the goal of the radiographic progression-free survival target in test patients.
Drugs Health Pharma

AstraZeneca stops prostate cancer trial, Q1 revenue up 10% to $13.6b

HQ Team April 29, 2025: British-Swedish pharmaceutical company AstraZeneca Plc. has discontinued its prostate cancer trial as it failed to meet the goal

Read More